Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7688)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 18, 2017 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mohamed AA, Ali-Eldin ZA, Elbedewy TA, El-Serafy M, Ali-Eldin FA, AbdelAziz H. MicroRNAs and clinical implications in hepatocellular carcinoma. World J Hepatol 2017; 9(23): 1001-1007 [PMID: 28878865 DOI: 10.4254/wjh.v9.i23.1001] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i23/1001.htm |
| Number | Citing Articles |
| 1 |
Aicheng Yang, Fanna Liu, Baozhang Guan, Zhi Luo, Jiehua Lin, Wan Fang, Longhui Liu, Wanli Zuo. p53 induces miR‐199a‐3p to suppress mechanistic target of rapamycin activation in cisplatin‐induced acute kidney injury. Journal of Cellular Biochemistry 2019; 120(10): 17625 doi: 10.1002/jcb.29030
|
| 2 |
Lichao Yang, Chunmeng Wei, Yasi Li, Xiao He, Min He. miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers. Biomarkers in Medicine 2020; 14(15): 1485 doi: 10.2217/bmm-2020-0099
|
| 3 |
Yien Xiang, Yongsheng Yang, Chao Lin, Jiacheng Wu, Xuewen Zhang. MiR-23a-3p promoted G1/S cell cycle transition by targeting protocadherin17 in hepatocellular carcinoma. Journal of Physiology and Biochemistry 2020; 76(1): 123 doi: 10.1007/s13105-020-00726-4
|
| 4 |
Eiichiro Suzuki, Tetsuhiro Chiba, Naoya Kato. Biomarkers in Cancer Therapy. 2019; : 87 doi: 10.1007/978-981-13-7295-7_8
|
| 5 |
Tommaso Mello, Irene Simeone, Andrea Galli. Mito-Nuclear Communication in Hepatocellular Carcinoma Metabolic Rewiring. Cells 2019; 8(5): 417 doi: 10.3390/cells8050417
|
| 6 |
Ting Song, Li Li, Shaobo Wu, Yan Liu, Caiping Guo, Wen Wang, Lili Dai, Tong Zhang, Hao Wu, Bin Su. Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.583714
|
| 7 |
Junsheng Gu, Xiaorui Liu, Juan Li, Yuting He. MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0729-x
|
| 8 |
Dhatri Madduru, Johny Ijaq, Sujata Dhar, Saumyadip Sarkar, Naresh Poondla, Partha S. Das, Silvia Vasquez, Prashanth Suravajhala. Systems Challenges of Hepatic Carcinomas: A Review. Journal of Clinical and Experimental Hepatology 2019; 9(2): 233 doi: 10.1016/j.jceh.2018.05.002
|
| 9 |
Amal A. Mohamed , Dina M. Abo-Elmatty , Omnia I ezzat , Ahmed A. Youssef , Eman T. Mehanna , Alshymaa A. Hassnine , Noha M. Mesbah, Salma Saed, Eman Al Sayed , Mahmoud Hamada , Afaf F. Khamis, Ayman Elshentenawy, Marwa S.E. Abd El-Raouf, Sherief Abd-Elsalam, Amr M. Elsayed . Expression of a Disintegrin and Metalloprotease 10 Gene Polymorphisms in a Cohort of Egyptian Patients with Hepatocellular Carcinoma. Current Cancer Therapy Reviews 2021; 17(4): 312 doi: 10.2174/1573394717666210427122703
|
| 10 |
Beilei Zhang, Xinan Wang, Jiacong Deng, Haifeng Zheng, Wei Liu, Si Chen, Jie Tian, Fu Wang. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma. Cancer Letters 2019; 459: 50 doi: 10.1016/j.canlet.2019.05.042
|
| 11 |
Manuela Cabiati, Costanza Salvadori, Giuseppina Basta, Serena Del Turco, Paolo Aretini, Antonella Cecchettini, Silvia Del Ry. miRNA and long non-coding RNA transcriptional expression in hepatocellular carcinoma cell line-secreted extracellular vesicles. Clinical and Experimental Medicine 2022; 22(2): 245 doi: 10.1007/s10238-021-00744-6
|
| 12 |
Yun Zhao, Shanel Dhani, Boris Zhivotovsky. Unveiling caspase-2 regulation by non-coding RNAs. Cell Death & Disease 2022; 13(9) doi: 10.1038/s41419-022-05270-1
|
| 13 |
Felice De Stefano, Eduardo Chacon, Lilia Turcios, Francesc Marti, Roberto Gedaly. Novel biomarkers in hepatocellular carcinoma. Digestive and Liver Disease 2018; 50(11): 1115 doi: 10.1016/j.dld.2018.08.019
|
| 14 |
Qian Yang, Lunli Zhang, Yuanbin Zhong, Lingling Lai, Xiaopeng Li. miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma. Bioscience Reports 2019; 39(5) doi: 10.1042/BSR20181823
|
| 15 |
Alisa Petkevich, Aleksandr Abramov, Vadim Pospelov. Liver Cancer - Genesis, Progression and Metastasis. 2023; doi: 10.5772/intechopen.106171
|
| 16 |
Chitra Jeyaram, Manuel Philip, Rajadurai Chinnasamy Perumal, Jubina Benny, Jayasankar Madusoodhanan Jayakumari, Maniramakrishnan Santhana Ramasamy. A Computational Approach to Identify Novel Potential Precursor miRNAs and their Targets from Hepatocellular Carcinoma Cells. Current Bioinformatics 2018; 14(1): 24 doi: 10.2174/1574893613666180413150351
|
| 17 |
Tao Zhou, Guowei Qin, Liehong Yang, Daokang Xiang, Suining Li. LncRNA XIST regulates myocardial infarction by targeting miR‐130a‐3p. Journal of Cellular Physiology 2019; 234(6): 8659 doi: 10.1002/jcp.26327
|
| 18 |
Merricka C. Livingstone, Natalie M. Johnson, Bill D. Roebuck, Thomas W. Kensler, John D. Groopman. Serum miR‐182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats. Molecular Carcinogenesis 2019; 58(11): 2017 doi: 10.1002/mc.23093
|
| 19 |
José Debes, Pablo Romagnoli, Jhon Prieto, Marco Arrese, Angelo Mattos, André Boonstra. Serum Biomarkers for the Prediction of Hepatocellular Carcinoma. Cancers 2021; 13(7): 1681 doi: 10.3390/cancers13071681
|
| 20 |
Seyed Mahdi Hosseiniyan Khatibi, Farima Najjarian, Hamed Homaei Rad, Mohammadreza Ardalan, Mohammad Teshnehlab, Sepideh Zununi Vahed, Saeed Pirmoradi. Key therapeutic targets implicated at the early stage of hepatocellular carcinoma identified through machine-learning approaches. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-30720-x
|
| 21 |
Qiyu Sun, Jian Li, Boxun Jin, Tiezheng Wang, Jiannan Gu. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage. Clinics and Research in Hepatology and Gastroenterology 2020; 44(1): 21 doi: 10.1016/j.clinre.2019.03.011
|
| 22 |
Cheng Peng, Yanshuo Ye, Zhanpeng Wang, Lianyue Guan, Suriguga Bao, Bo Li, Wei Li. Circulating microRNAs for the diagnosis of hepatocellular carcinoma. Digestive and Liver Disease 2019; 51(5): 621 doi: 10.1016/j.dld.2018.12.011
|
| 23 |
Amal Ahmed Mohamed, Omnia Ezzat Esmail, Aya Mohamed Ahmed Ibrahim, Sahar Makled, Eman Al‐Hussain, Ali Elsaid, Mohamed Alboraie, Rehab R. El‐Awady. The role of PRDM1 gene polymorphism in the progression of hepatocellular carcinoma in Egyptian patients. Journal of Medical Virology 2023; 95(1) doi: 10.1002/jmv.28343
|
| 24 |
Iwona Rzeszutek, Aditi Singh. Small RNAs, Big Diseases. International Journal of Molecular Sciences 2020; 21(16): 5699 doi: 10.3390/ijms21165699
|
| 25 |
Ester Badami, Claudia Carcione, Cinzia Maria Chinnici, Rosaria Tinnirello, Pier Giulio Conaldi, Gioacchin Iannolo. HCV Interplay With Mir34a: Implications in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.803278
|
| 26 |
Masamichi Hayashi, Suguru Yamada, Keisuke Kurimoto, Hiroshi Tanabe, Sho Hirabayashi, Fuminori Sonohara, Yoshikuni Inokawa, Hideki Takami, Mitsuro Kanda, Chie Tanaka, Goro Nakayama, Masahiko Koike, Yasuhiro Kodera. miR-23b-3p Plays an Oncogenic Role in Hepatocellular Carcinoma. Annals of Surgical Oncology 2021; 28(6): 3416 doi: 10.1245/s10434-020-09283-y
|
| 27 |
Lang-Qing Sheng, Jia-Rong Li, Hao Qin, Ling Liu, Da-Dong Zhang, Qi Zhang, Meng-Li Huang, Xiao-Li Li, Xiao-Ya Xu, Yang-Nian Wei, Zi-Shuo Chen, Hui Luo, Ji-Yang Zhang, Cheng-Hui Zhou, Hao Chen, Ze-Guo Chen, Fu-Gen Li, Nian-Feng Li. Blood exosomal micro ribonucleic acid profiling reveals the complexity of hepatocellular carcinoma and identifies potential biomarkers for differential diagnosis. World Journal of Gastrointestinal Oncology 2020; 12(10): 1195-1208 doi: 10.4251/wjgo.v12.i10.1195
|
| 28 |
Nabil Mohie Abdel-Hamid, Shimaa Ali Abass. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_148-1
|
| 29 |
Kunsong Zhang, Zhenxian Zhao, Junfeng Yu, Wei Chen, Qiongcong Xu, Liuhua Chen. LncRNA FLVCR1‐AS1 acts as miR‐513c sponge to modulate cancer cell proliferation, migration, and invasion in hepatocellular carcinoma. Journal of Cellular Biochemistry 2018; 119(7): 6045 doi: 10.1002/jcb.26802
|
| 30 |
Hong Xin, Chengliang Li, Tianzhi Cai, Jinlong Cao, Meixue Wang. LncRNA KCNQ1OT1 contributes to hydrogen peroxide‐induced apoptosis, inflammation, and oxidative stress of cardiomyocytes via miR‐130a‐3p/ZNF791 axis. Cell Biology International 2022; 46(12): 2018 doi: 10.1002/cbin.11873
|
| 31 |
Haruhiro Yamashita, Sailesh Surapureddi, Ramesh C. Kovi, Sachin Bhusari, Thai Vu Ton, Jian-Liang Li, Keith R. Shockley, Shyamal D. Peddada, Kevin E. Gerrish, Cynthia V. Rider, Mark J. Hoenerhoff, Robert C. Sills, Arun R. Pandiri. Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice. Archives of Toxicology 2020; 94(7): 2523 doi: 10.1007/s00204-020-02749-8
|
| 32 |
Wei Zhao, Xue Jiang, Shuxia Yang. <p>lncRNA TUG1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma via Regulating miR-29c-3p/<em>COL1A1</em> Axis</p>. Cancer Management and Research 2020; : 6837 doi: 10.2147/CMAR.S256624
|
| 33 |
Kuei-Min Chung, Ya-Ting Chen, Chih-Chen Hong, Il-Chi Chang, Si-Ying Lin, Li-Yu Liang, Yi-Rong Chen, Chau-Ting Yeh, Shiu-Feng Huang. CA10 is associated with HBV-related hepatocarcinogenesis. Biochemistry and Biophysics Reports 2022; 31: 101303 doi: 10.1016/j.bbrep.2022.101303
|
| 34 |
Srinivasulu Yerukala Sathipati, Shinn-Ying Ho. Novel miRNA signature for predicting the stage of hepatocellular carcinoma. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-71324-z
|
| 35 |
Ying Zan, Baofeng Wang, Liang Liang, Yujiao Deng, Tian Tian, Zhijun Dai, Lei Dong. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1175-2
|
| 36 |
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
|
| 37 |
Seyed Mostafa Parizadeh, Reza Jafarzadeh-Esfehani, Maryam Ghandehari, Fatemeh Goldani, Seyed Mohammad Reza Parizadeh, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Amir Avan. MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. Current Drug Targets 2019; 20(11): 1129 doi: 10.2174/1389450120666190307095720
|
| 38 |
Lu Zhang, Yi Liao, Liling Tang. MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1059-5
|
| 39 |
Hend E. EL-shqnqery, Rania Hassan Mohamed, Omar Samir, Islam Ayoub, Wael M. El-Sayed, Ahmed A. Sayed. miRNome of Child A hepatocellular carcinoma in Egyptian patients. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1137585
|